Cardiovascular risk assessment: Addition of CKD and race to the Framingham equation.
Am. Heart J., Dec;164(6):925-931.e2 (2012)
How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure?
Stat Med., Sep (2012)
Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR.
Clin J Am Soc Nephrol., Jun;7(6):989-1002 (2012)
Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study.
PLoS ONE., 7(3):e34217 (2012)
Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Hypertension., May;59(5):926-33 (2012)
Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT Diabetes Extension Study.
Circ Cardiovasc Qual Outcomes., Mar;5(2):153-62 (2012)
Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study.
Pharmacogenet. Genomics., May;22(5):355-66 (2012)
Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
J Clin Hypertens (Greenwich)., Jan;14(1):20-31 (2012)
Secondary analyses in cardiovascular clinical trials - statistical and other considerations. Introduction.
Prog Cardiovasc Dis., 54(4):329 (2012 Jan-Feb)
Association between chlorthalidone treatment of systolic hypertension and long-term survival.
JAMA., Dec;306(23):2588-93 (2011)
The development of a minimally invasive cardiac surgery program: the Greenville experience.
J S C Med Assoc., Aug;107(4):129-32 (2011)
Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).
Circulation., Oct;124(17):1811-8 (2011)
Pharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patients with hypertension.
PLoS ONE., 6(8):e23609 (2011)
Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study.
Stroke., Feb;42(2):330-5 (2011)
Has oseltamivir been shown to be effective for treatment of H5N1 influenza?
J. Infect. Dis., Oct;202(8):1149-51 (2010)
Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study.
J. Hypertens., Oct;28(10):2076-83 (2010)
ALLHAT: still providing correct answers after 7 years.
Curr. Opin. Cardiol., Jul;25(4):355-65 (2010)
Impact of the ALLHAT/JNC7 Dissemination Project on thiazide-type diuretic use.
Arch. Intern. Med., May;170(10):851-8 (2010)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.
Lancet., Feb;375(9716):735-42 (2010)
Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
J. Am. Coll. Cardiol., Nov;54(22):2023-31 (2009)